PLEASE LOGIN OR REGISTER
In order to register for a webinar you must be a member of our website. If you already have an account, please login.
Register Now Login
Speaker Information
Dr. Nisha D’Silva
Nisha D’Silva is the Donald Kerr Endowed Collegiate Professor of Oral Pathology at the University of Michigan School of Dentistry, Professor of Pathology at the Medical School, and Rogel Scholar at the Rogel Comprehensive Cancer Center. She is a dentist-scientist; Dr. D’Silva is a Diplomate of the American Board of Oral and Maxillofacial Pathology, which is her area of clinical practice. She enjoys teaching dental students. She also mentors PhD students, post-doctoral fellows, and junior faculty and is the recipient of multiple mentorship awards. Her translational research in oral and oropharyngeal cancers focuses on tumor development, progression and treatment resistance. She is President of the American Association of Dental Oral and Craniofacial Research. Dr. D’Silva has been the recipient of multiple National Institutes of Health grants and is currently funded by the National Institute of Dental and Craniofacial Research and by the National Cancer Institute. She has published 115 scientific papers.
Dr. Kıvanç Bektaş-Kayhan
Kıvanç Bektaş Kayhan was born in İzmir, Türkiye, in 1976. She graduated from the Istanbul University Faculty of Dentistry in 2000 and, in the same year, was admitted to the PhD program in the Department of Oral and Maxillofacial Surgery at the same institution. In 2006, she completed her doctoral thesis entitled “Investigation of L-myc Gene Polymorphism in Patients with Oral Squamous Cell Carcinoma” and received the degree of Dr. Med. Dent.
Prof. Kayhan continued her academic career within the same department, earning the title of Associate Professor in 2013 and Full Professor in 2022. She is currently a faculty member in the Department of Oral and Maxillofacial Surgery at Istanbul University Faculty of Dentistry, where she continues her academic, clinical, and research activities.
She is the co-author of a book with Prof. Dr. Meral Ünür, has contributed chapters to several national and international books, and has published more than 100 scientific articles in peer-reviewed journals. In addition, she has received two international scientific awards in recognition of her academic contributions.
Her primary research interests include oral oncology, medication-related osteonecrosis of the jaw (MRONJ), oral potentially malignant disorders, and the oral complications of systemic diseases and cancer therapies.
She serves as;
ISOO (International Society of Oral Oncology) Board Member,
Member of FDI Scientific Committee,
ACBID, Turkish Oral & Maxillofacial Surgery Society, Medication Related Osteonecrosis of Jaws (MRONJ) Working Group Chair,
Member of Foreign Relations Commission in Turkish Dental Association
Delegate of İstanbul Chamber of Dentists
She continues to work as a working group member in international associations such as Multinational Association of Supportive Care for Cancer (MASCC), EAOM (European Association of Oral Medicine).
Share on social media:
Supported by:
FDI World Dental Federation
FDI World Dental Federation
58 Comments
Thanks
Thanks for webinar
🙂 Gracias
thank you again!
For the CE, after the webinar, please click on CE Certificate to access the quiz or please use this link https://www.fdioralhealthcampus.org/webinar/hpv-and-oral-health-turning-routine-care-into-cancer-prevention/?sb=ce-certificate. It will not be provided via email. Thank you
How to get certificate for attending this webinar? Please provide it via email
Hi, from porto.
Are there statistics of patients survival who have surgery?
This infection Common among male or female?
Are males vaccinated less than females?
Is the clinical presentation of these oral lesions/tumor similar in appearance and presentation to non-HPVSCC?
Thank you Doctors for providing information we need with directions on how to approach parents and patients. Prevention is the outcome but also treatment options to get the patients to optimal health.
Thank you for this presentation. Greetings from Papua New Guinea.
How you can overcome the cultural differences in a country like mine Iran
@ Helene B: That wasn’t my question! I must have forwarded my link to others. I thought legal in Oregon too
How long does it take to manifest after being infected and are their factors that contribute to this?
@Christopher Fox I thought legal in MA
If vaccinated after 40 years, how far is it effective?
Thanks for answering the question.
Thank you.
Do you work on clinical trials related to HPV? I am interested to know if the possibility of original work is possible as most patients are not easy to follow up regularly.
Is it better to refer to ENT than Oral Surgeon or does it matter?
How can I find out which type of HPV it is?
Great presentation and very informative.
May the mass located under lower border of mandible?
Does HPV related OPC occur commonly in children?
Is the HPV vaccine safe to administer to patients with autoimmune diseases?
What about those above 26 years? Any preventive measures?
How can dentists assess Vaccine hesistancy among parents and do change communications?
Thank you for the timely and interesting information.
With a focus on raising awareness and prevention. How do we begin to introduce the mode of spread of HPV with our patients, via intimate skin to skin contact – oral sex
What is a time window for vaccination?
Can it be done in very old age too?
Buenos días desde el Perú 😊
How do you address the issues related to HPV infection and Social stigma
do adults need to be revaccinated at any time?
Thanks, from Porto, Portugal
what is the appropriate age to get vaccinated?
Thank you
Thank you very much! It was very interesting.
thank you!
how do you follow-up with patients you refer? does your office staff check with patients to see if they follow through with specialist?
How can we manage oropharyngeal risks of hpv 16 positive patients if she is got diagnosed from the gynecology. Because theirs screening much more easier and routined.
Good afternoon from Istanbul, Türkiye. 🙂
Amazing knowledge and information 👌👏👏👏👏
Kindly suggest Preventive approach for developing countries
Afternoon from Scotland
Hi, Greetings from Çapa
There was a period of time in the U.S. where tonsillectomy was a common treatment for tonsilitis. Now antibiotics are the more common treatment. Is there a protective effect amongst those adults who have had a tonsillectomy and HPV infection?
hello from india
hi from NYC
Good morning from Nashville, TN
Yes, this webinar will be available from tomorrow onwards on demand. Thank you
Good afternoon from Nigeria.
Good afternoon from 🇦🇫 Afghanistan
Good Evening from Myanmar
Will the slides/recording be made available?
Can you explain low vaccine uptake? I was under the impression that the HPV vaccine is helping prevent?
Is the dentists legal alowed to apply Vacinations in all contries?
Good morning from Arizona
Thank you for joining today’s webinar with Dr. Nisha D’Silva and Dr. Kıvanç Bektaş-Kayhan. If you have any questions for our expert about today’s presentation, please write them in this chat box and they will be addressed during the Q&A session.